News | February 07, 2026
Hologic’s Aptima HPV test bags FDA nod for primary cervical cancer screening
Hologic has been at the forefront of cervical cancer screening for decades
Hologic has been at the forefront of cervical cancer screening for decades
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
